Are you looking to invest in companies with a good shot at growing even faster than the U.S. technology giants that have been performing so well? Michael Santoli pointed out in this CNBC article that the S&P 500 Life Sciences Tools and Services subsector has greatly outperformed the broader market this year. Following his lead, we have taken a deeper dive to highlight more of the growth leaders that distribute and sell supplies and devices to biotechnology and other health-care companies. The S&P 500 Life Sciences Tools and Services subsector is made up of seven large-cap companies, and the S&P Composite 1500 Life Sciences Tools and Services subsector adds small-cap and mid-cap companies for a total of 14 stocks. Here’s how the S&P Composite 1500 Life Sciences Tools and Services subsector has performed this year against the S&P Composite 1500 health-care sector and the entire S&P 1500: FactSet The longer-term story also is a good one. Here’s a three-year total return comparison: FactSet And five years: via